The immunological aspects of malignant disease.
D000328:Adult; D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002648:Child; D000939:Epitopes; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007114:Immunization; D007116:Immunization, Passive; D007167:Immunotherapy; D007945:Leukemia, Lymphoid / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D051379:Mice; D009163:Mycobacterium bovis / Q000276:immunology; D009363:Neoplasm Proteins / Q000276:immunology; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D012075:Remission, Spontaneous; D013601:T-Lymphocytes / Q000276:immunology; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen; D000939:Epitopes; D006680:HLA Antigens; D009363:Neoplasm Proteins; D000509:alpha-Fetoproteins